Bullivant Houser Bailey defended a Fortune 100 company on claims arising from a hostile takeover bid. The class action suit alleged that the acquisition triggered a “poison pill” in the target’s pension plan. Assets at stake were over $20 million. Bullivant won the case on summary judgment.